Nkarta Market Capitalization from 2010 to 2024
| NKTX Stock | USD 2.59 0.14 5.71% |
Check Nkarta financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nkarta's main balance sheet or income statement drivers, such as Net Interest Income of 14.2 M, Interest Income of 14.2 M or Depreciation And Amortization of 6.2 M, as well as many indicators such as Price To Sales Ratio of 4.1 K, Dividend Yield of 0.0 or PTB Ratio of 1.24. Nkarta financial statements analysis is a perfect complement when working with Nkarta Valuation or Volatility modules.
Nkarta | Market Capitalization |
Latest Nkarta's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Nkarta Inc over the last few years. It is Nkarta's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nkarta's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 182.77 M | 10 Years Trend |
|
Market Cap |
| Timeline |
Nkarta Market Capitalization Regression Statistics
| Arithmetic Mean | 144,725,231,990 | |
| Geometric Mean | 19,688,398,769 | |
| Coefficient Of Variation | 84.15 | |
| Mean Deviation | 115,281,968,954 | |
| Median | 240,793,539,452 | |
| Standard Deviation | 121,789,445,373 | |
| Sample Variance | 14832669004.2T | |
| Range | 240.5B | |
| R-Value | (0.85) | |
| Mean Square Error | 4410832783.8T | |
| R-Squared | 0.72 | |
| Significance | 0.000058 | |
| Slope | (23,169,911,205) | |
| Total Sum of Squares | 207657366059T |
Nkarta Market Capitalization History
About Nkarta Financial Statements
Nkarta investors use historical fundamental indicators, such as Nkarta's Market Capitalization, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Nkarta. Please read more on our technical analysis and fundamental analysis pages.
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California. Nkarta operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 127 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Nkarta Stock Analysis
When running Nkarta's price analysis, check to measure Nkarta's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nkarta is operating at the current time. Most of Nkarta's value examination focuses on studying past and present price action to predict the probability of Nkarta's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nkarta's price. Additionally, you may evaluate how the addition of Nkarta to your portfolios can decrease your overall portfolio volatility.